Table 4.
Antihypertensive medicine use and the control rate of hypertension among 546 anti-hypertensive treatments patients
n | Percentages (%) | Control (n, %) | |
---|---|---|---|
Monotherapy* | 454 | 83.2 | 51 (11.2) |
TDs | 19 | 4.2 | 6 (31.6) |
CCBs | 215 | 47.4 | 21 (9.8) |
BBs | 5 | 1.1 | 1 (20.0) |
ACEIs | 28 | 6.2 | 2 (7.1) |
ARBs | 42 | 9.3 | 4 (9.5) |
Other | 145 | 31.9 | 17 (11.7) |
Combination therapy | 92 | 16.8 | 9 (9.8) |
Abbreviations: TDs thiazide-type diuretics, CCBs calcium channel blockers, BBs β-blockers, ACEIs angiotensin-converting-enzyme inhibitors, ARBs angiotensin receptor blockers